SciSparc Ltd.
SPRC · XNASCIK 1611746fmd_1ES0RKT0321PQ7X5HZNT4ABQMRManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Dec 31, 2025, 20 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | – | – | – | 1 | 3 | 1 |
| Cost of revenue | – | – | – | – | – | – | – | 0 | 1 | 1 |
| Gross profit | – | – | – | – | – | – | – | 1 | 2 | 1 |
| Research and development | (0) | 1 | 2 | 3 | 2 | 1 | 2 | 3 | 2 | 2 |
| Selling, general and administrative | – | – | – | – | 2 | 2 | 4 | 6 | 5 | – |
| Operating income | 3 | (2) | (6) | (7) | (4) | (3) | (6) | (8) | (7) | (7) |
| Interest expense | (0) | 0 | 0 | 0 | 1 | 1 | 0 | 2 | 1 | 0 |
| Income before taxes | 3 | (2) | (6) | (9) | – | (4) | (6) | (3) | (6) | (7) |
| Income tax expense | – | – | – | (0) | – | – | – | 0 | 0 | (0) |
| Net income from continuing operations | – | – | (6) | (7) | (4) | (4) | (6) | (3) | (6) | (7) |
| Net income | 3 | 2 | 6 | 7 | 5 | 4 | (6) | (3) | (5) | (6) |
| Net income to common shareholders | (3) | (2) | (6) | (9) | – | – | – | – | – | – |